tiprankstipranks
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
Holding CMMB?
Track your performance easily

Chemomab Therapeutics (CMMB) Technical Analysis

232 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Chemomab Therapeutics’s (CMMB) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Chemomab Therapeutics is a Buy.
Chemomab Therapeutics’s (CMMB) 20-Day exponential moving average is 1.66, while Chemomab Therapeutics’s (CMMB) share price is $1.68, making it a Buy.
Chemomab Therapeutics’s (CMMB) 50-Day exponential moving average is 1.61, while Chemomab Therapeutics’s (CMMB) share price is $1.68, making it a Buy.

Chemomab Therapeutics (CMMB) Pivot Points

Dec 22, 2024, 12:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.46
1.51
1.56
1.61
1.66
1.71
1.76
Fibonacci
1.51
1.55
1.57
1.61
1.64
1.67
1.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Chemomab Therapeutics (CMMB) Moving Averages

Dec 22, 2024, 12:26 PM
Period
Simple
Exponential
MA5
1.63Buy
1.65Buy
MA10
1.66Buy
1.65Buy
MA20
1.68Sell
1.66Buy
MA50
1.57Buy
1.61Buy
MA100
1.55Buy
1.50Buy
MA200
1.23Buy
1.22Buy
Chemomab Therapeutics’s (CMMB) 10-Day exponential moving average is 1.65, while Chemomab Therapeutics’s (CMMB) share price is $1.68, making it a Buy.
Chemomab Therapeutics’s (CMMB) 100-Day exponential moving average is 1.50, while Chemomab Therapeutics’s (CMMB) share price is $1.68, making it a Buy.
Chemomab Therapeutics’s (CMMB) stock price is $1.68 and Chemomab Therapeutics’s (CMMB) 50-day simple moving average is 1.57, creating a Buy signal.
Chemomab Therapeutics’s (CMMB) stock price is $1.68 and Chemomab Therapeutics’s (CMMB) 100-day simple moving average is 1.55, creating a Buy signal.
Chemomab Therapeutics’s (CMMB) stock price is $1.68 and Chemomab Therapeutics’s (CMMB) 200-day simple moving average is 1.23, creating a Buy signal.

Chemomab Therapeutics (CMMB) Technical Indicators

Dec 22, 2024, 12:26 PM
Name
Value
Implied Action
RSI (14)
52.42
Neutral
STOCH (9,6)
31.25
Neutral
STOCHRSI (14)
25.98
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
17.05
Buy
Williams %R
-60.53
Buy
CCI (14)
-36.18
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
46.05
Neutral
ROC
-6.15
Sell
Chemomab Therapeutics’s (CMMB) Relative Strength Index (RSI) is 52.42, creating a Neutral signal.
Chemomab Therapeutics’s (CMMB) Trend Strength Indicator (ADX) is 17.05, creating a Buy signal.
Chemomab Therapeutics’s (CMMB) Commodity Channel Index (CCI) is -36.18, creating a Neutral signal.
Chemomab Therapeutics’s (CMMB) Price Rate of Change (ROC) is -6.15, creating a Sell signal.

FAQ

Is CMMB a Buy, Hold, or Sell?
Based on CMMB’s technical indicators, CMMB is a Buy.
    What is CMMB’s RSI (14)?
    CMMB’s RSI (14) is 52.42, which suggests CMMB is a Neutral.
      What is CMMB’s MACD?
      CMMB’s MACD is <0.01, which suggests CMMB is a Buy.
        What is CMMB’s 5-day moving average?
        CMMB’s 5-day moving average is 1.63, which suggests CMMB is a Buy.
          What is CMMB’s 20-day moving average?
          CMMB 20-day moving average is 1.68, which suggests CMMB is a Sell.
            What is CMMB’s 50-day moving average?
            CMMB’s 50-day moving average is 1.57, which suggests CMMB is a Buy.
              What is CMMB’s 200-day moving average?
              CMMB’s 200-day moving average is 1.23, which suggests CMMB is a Buy.
                What is CMMB’s Williams % R (14)?
                CMMB’s Williams % R (14) is -60.53, which suggests CMMB is a Buy.
                  What is CMMB’s CCI (14)?
                  CMMB’s CCI (14) is -36.18, which suggests CMMB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis